 II. Evaluate on-treatment changes in density of and proximity between immune cell subsets in the tumor microenvironment after immunogenic chemotherapy alone and R-GEMOX-ATEZO by multispectral immunofluorescence, including density of CD8 cells and cytotoxic lymphocyte CTL:regulatory T cell Treg ratio. 